APA (7th ed.) Citation

LD, P., A, S., SE, P., J, B., JB, R., M, B., . . . CJ, S. (2026). Timing of Effect Onset After Restarting Anti CGRP-(Receptor)-Monoclonal Antibodies Following a Mandatory Cessation After One year of Use-A Single Center Retrospective Cohort Study. Drug design, development and therapy, 20, 567680. https://doi.org/10.2147/DDDT.S567680

Chicago Style (17th ed.) Citation

LD, Panos, Scutelnic A, Plüss SE, Bracher J, Rossel JB, Branca M, Riederer F, and Schankin CJ. "Timing of Effect Onset After Restarting Anti CGRP-(Receptor)-Monoclonal Antibodies Following a Mandatory Cessation After One Year of Use-A Single Center Retrospective Cohort Study." Drug Design, Development and Therapy 20 (2026): 567680. https://doi.org/10.2147/DDDT.S567680.

MLA (9th ed.) Citation

LD, Panos, et al. "Timing of Effect Onset After Restarting Anti CGRP-(Receptor)-Monoclonal Antibodies Following a Mandatory Cessation After One Year of Use-A Single Center Retrospective Cohort Study." Drug Design, Development and Therapy, vol. 20, 2026, p. 567680, https://doi.org/10.2147/DDDT.S567680.